Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Gilbertson

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Current Oncology (Toronto, Ont.)|October 25, 2013
Breast cancer and the environment: why research and preventive action are neededJames T Brophy, Margaret M Keith, Robert Park, et al.
Blood Advances|October 9, 2021
Salvage radiotherapy is associated with durable response for a subset of patients with limited-stage refractory DLBCLJemima H Miller, Michael Gilbertson, Michael P MacManus, et al.
Pathology|September 1, 2012
Is CD20 positive plasma cell myeloma a unique clinicopathological entity? A study of 40 cases and review of the literatureGeorge Grigoriadis, Michael Gilbertson, Neil Came, et al.
Annals of Hematology|January 24, 2016
Infusional dose-adjusted epoch plus bortezomib for the treatment of plasmablastic lymphomaPasquale L Fedele, Gareth P Gregory, Michael Gilbertson, et al.
British Journal of Cancer|July 24, 2018
Routine blood investigations have limited utility in surveillance of aggressive lymphoma in asymptomatic patients in complete remissionEliza A Hawkes, Zoe Loh, Ortis Estacio, et al.
International Journal of Occupational and Environmental Health|May 30, 2008
Sex ratio changes as sentinel health events of endocrine disruptionNicolas A van Larebeke, Annie J Sasco, James T Brophy, et al.
Scientific Reports|July 2, 2017
Infection is an Independent Predictor of Death in Diffuse Large B Cell LymphomaClaire Dendle, Michael Gilbertson, Tim Spelman, et al.
British Journal of Haematology|September 1, 2017
Failure to achieve early disease response is associated with inferior survival in patients with newly diagnosed multiple myelomaAdrian Chee, Michael S Low, Shahla Vilcassim, et al.
British Journal of Haematology|July 30, 2016
High-dose therapy and autologous stem cell transplantation may only be applicable to selected patients with secondary CNS diffuse large B-cell lymphomaChan Yoon Cheah, David Joske, Gavin Cull, et al.
Internal Medicine Journal|January 19, 2021
Safety of rapid injection of undiluted ferric carboxymaltose to patients with iron-deficiency anaemia: a Phase II single-arm studySant-Rayn Pasricha, Michael Gilbertson, Tishya Indran, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Current Oncology (Toronto, Ont.)|October 25, 2013
Breast cancer and the environment: why research and preventive action are neededJames T Brophy, Margaret M Keith, Robert Park, et al.
Blood Advances|October 9, 2021
Salvage radiotherapy is associated with durable response for a subset of patients with limited-stage refractory DLBCLJemima H Miller, Michael Gilbertson, Michael P MacManus, et al.
Pathology|September 1, 2012
Is CD20 positive plasma cell myeloma a unique clinicopathological entity? A study of 40 cases and review of the literatureGeorge Grigoriadis, Michael Gilbertson, Neil Came, et al.
Annals of Hematology|January 24, 2016
Infusional dose-adjusted epoch plus bortezomib for the treatment of plasmablastic lymphomaPasquale L Fedele, Gareth P Gregory, Michael Gilbertson, et al.
British Journal of Cancer|July 24, 2018
Routine blood investigations have limited utility in surveillance of aggressive lymphoma in asymptomatic patients in complete remissionEliza A Hawkes, Zoe Loh, Ortis Estacio, et al.
International Journal of Occupational and Environmental Health|May 30, 2008
Sex ratio changes as sentinel health events of endocrine disruptionNicolas A van Larebeke, Annie J Sasco, James T Brophy, et al.
Scientific Reports|July 2, 2017
Infection is an Independent Predictor of Death in Diffuse Large B Cell LymphomaClaire Dendle, Michael Gilbertson, Tim Spelman, et al.
British Journal of Haematology|September 1, 2017
Failure to achieve early disease response is associated with inferior survival in patients with newly diagnosed multiple myelomaAdrian Chee, Michael S Low, Shahla Vilcassim, et al.
British Journal of Haematology|July 30, 2016
High-dose therapy and autologous stem cell transplantation may only be applicable to selected patients with secondary CNS diffuse large B-cell lymphomaChan Yoon Cheah, David Joske, Gavin Cull, et al.
Internal Medicine Journal|January 19, 2021
Safety of rapid injection of undiluted ferric carboxymaltose to patients with iron-deficiency anaemia: a Phase II single-arm studySant-Rayn Pasricha, Michael Gilbertson, Tishya Indran, et al.
Pageof 6